SENORES PHARMACEUTICALS
Back to Cashflow Statement
|
SENORES PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹573 Cr | ₹87 Cr | ₹46 Cr | ₹36 Cr |
What is the latest Cash Flow from Financing Activities ratio of SENORES PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹573 Cr |
| Mar2024 | ₹87 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹36 Cr |
How is Cash Flow from Financing Activities of SENORES PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹573 Cr | 558.92 | |
| Mar2024 | ₹87 Cr | 88.06 | |
| Mar2023 | ₹46 Cr | 26.84 | |
| Mar2022 | ₹36 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,686.3 Cr | 3.2% | 12.3% | 149.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 3.2% |
12.3% |
149.6% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses